<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36504922</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-7762</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Lancet regional health. Europe</Title><ISOAbbreviation>Lancet Reg Health Eur</ISOAbbreviation></Journal><ArticleTitle>Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months.</ArticleTitle><Pagination><StartPage>100554</StartPage><MedlinePgn>100554</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanepe.2022.100554</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Despite high numbers of children and young people (CYP) having acute COVID, there has been no prospective follow-up of CYP to establish the pattern of health and well-being over a year following infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A non-hospitalised, national sample of 5086 (2909 SARS-COV-2 Positive; 2177 SARS-COV-2 Negative at baseline) CYP aged 11-17 completed questionnaires 6- and 12-months after PCR-tests between October 2020 and March 2021 confirming SARS-CoV-2 infection (excluding CYP with subsequent (re)infections). SARS-COV-2 Positive CYP was compared to age, sex and geographically-matched test-negative CYP.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Ten of 21 symptoms had a prevalence less than 10% at baseline, 6- and 12-months post-test in both test-positives and test-negatives. Of the other 11 symptoms, in test-positives who had these at baseline, the prevalence of all symptoms declined greatly by 12-months. For CYP first describing one of these at 6-months, there was a decline in prevalence by 12-months. The overall prevalence of 9 of 11 symptoms declined by 12-months. As many CYP first described shortness of breath and tiredness at either 6- or 12-months, the overall prevalence of these two symptoms in test-positives appeared to increase by 6-months and increase further by 12-months. However, within-individual examination demonstrated that the prevalence of shortness of breath and tiredness actually declined in those first describing these two symptoms at either baseline or 6-months. This pattern was also evident for these two symptoms in test-negatives. Similar patterns were observed for validated measures of poor quality of life, emotional and behavioural difficulties, poor well-being and fatigue. Moreover, broadly similar patterns and results were noted for the sub-sample (N&#xa0;=&#xa0;1808) that had data at baseline, 3-, 6- and 12-months post-test.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">In CYP, the prevalence of adverse symptoms reported at the time of a positive PCR-test declined over 12-months. Some test-positives and test-negatives reported adverse symptoms for the first time at six- and 12-months post-test, particularly tiredness, shortness of breath, poor quality of life, poor well-being and fatigue suggesting they are likely to be caused by multiple factors.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">NIHR/UKRI (ref: COVLT0022).</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, Faculty of Medical Sciences, University College London, WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Hershel Smith Building Cambridge Biomedical Campus, CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Dougal</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mohn Centre for Children's Health &amp; Wellbeing, School of Public Health, Imperial College London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Infectious Diseases Research Group, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Sophie D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De'Crespigny Park, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Hershel Smith Building Cambridge Biomedical Campus, CB2 0SZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kishan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neuroscience &amp; Experimental Psychology, University of Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Simon R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Hershel Smith Building Cambridge Biomedical Campus, CB2 0SZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council Biostatistics Unit, University of Cambridge, East Forvie Building, Cambridge Biomedical Campus, CB2 0SR, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_UU_00002/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P020372/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Eur</MedlineTA><NlmUniqueID>101777707</NlmUniqueID><ISSNLinking>2666-7762</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CYP, Children and young people</Keyword><Keyword MajorTopicYN="N">Children and young people</Keyword><Keyword MajorTopicYN="N">IQR, Interquartile range</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Longitudinal</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword><Keyword MajorTopicYN="N">UKHSA, United Kingdom Health Security Agency</Keyword><Keyword MajorTopicYN="N">Well-being</Keyword></KeywordList><CoiStatement>Terence Stephenson is Chair of the 10.13039/100005622Health Research Authority and therefore recused himself from the Research Ethics Application. Trudie Chalder is a member of the National Institute for Health and Care Excellence committee for long COVID. She has written self-help books on chronic fatigue and has done workshops on chronic fatigue and post infectious syndromes. Dougal Hargreaves had a part-time secondment as Deputy Chief Scientific Adviser from September 2020 to September 2021, whereby his salary for 2 days per week was paid by the Department for Education (England) to Imperial College London. Sophie Bennett and Roz Shafran are both part of Great Ormond Street Hospital 10.13039/100015819NHS Foundation Trust and UCL 10.13039/501100001282Great Ormond Street Institute of Child Health, where their research is made possible by the National Institute of Health Research (NIHR) 10.13039/501100019256Great Ormond Street Hospital Biomedical Research Centre. Sophie Bennett and Roz Shafran are co-authors on a book published in August 2020, titled Oxford Guide to Brief and Low Intensity Interventions for Children and Young People. All remaining authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36504922</ArticleId><ArticleId IdType="pmc">PMC9719829</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2022.100554</ArticleId><ArticleId IdType="pii">S2666-7762(22)00250-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky J.R., Tao G., Lavery A.M., et al. Late conditions diagnosed 1-4 Months following an initial coronavirus disease 2019 (COVID-19) encounter: A matched-cohort study using inpatient and outpatient administrative data-United States, 1 March-30 June 2020. Clin Infect Dis. 2021;73(Suppl 1):S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J&#xa0;Infect. 2022;84(2):158&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero Diego K.L., Marie Dauvrin, Jens Detollenaere, et al.  Long COVID: Pathophysiology &#x2013; epidemiology and patient needs. 2021. https://database.inahta.org/article/20213</Citation></Reference><Reference><Citation>Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Skyrud K.D., Suren P., et al. Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ. 2022;376</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762452</ArticleId><ArticleId IdType="pubmed">35039315</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolescent Health. 2022;6(4):240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., De Stavola B., et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study) BMJ Open. 2021;11(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolescent Health. 2022;6(4):230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Buonsenso D., Dunn, et al.  ISARIC Global COVID-19 paediatric follow-up. 2021. https://isaric.org/research/covid-19-clinical-research-resources/paediatric-follow-up/</Citation></Reference><Reference><Citation>NHS Digital  Mental health of children and young people in England, 2020: Wave 1 follow up to the 2017 survey. 2020. https://tinyurl.com/NHSWave1FU</Citation></Reference><Reference><Citation>Office for National Statistics  Measuring loneliness: guidance for use of the national indicators on surveys. 2018. https://www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/methodologies/measuringlonelinessguidanceforuseofthenationalindicatorsonsurveys#recommended-measures-for-children</Citation></Reference><Reference><Citation>Klein E.M., Zenger M., Tibubos A.N., et al. Loneliness and its relation to mental health in the general population: Validation and norm values of a brief measure. J&#xa0;Affect Disord Rep. 2021;4</Citation></Reference><Reference><Citation>Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J&#xa0;Am Acad Child Adolesc Psychiatry. 2001;40(11):1337&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">11699809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant R., Hiller L., Fishwick R., et al. The warwick-edinburgh mental well-being scale (WEMWBS): development and UK validation. Health Qual Life Outcome. 2007;5:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2222612</ArticleId><ArticleId IdType="pubmed">18042300</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Outcomes Research Consortium  Short warwick-edinburgh mental wellbeing scale (SWEMWS) 2022. https://www.corc.uk.net/outcome-experience-measures/short-warwick-edinburgh-mental-wellbeing-scale-swemws/</Citation></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J&#xa0;Psychosom Res. 1993;37(2):147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille N., Badia X., Bonsel G., et al. Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892611</ArticleId><ArticleId IdType="pubmed">20405245</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107(7):674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S.K., Palm P., Nielsen S.D., et al. Acute symptoms in SARS-CoV-2 positive adolescents aged 15-18 years - results from a Danish national cross-sectional survey study. Lancet Reg Health Eur. 2022;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8947819</ArticleId><ArticleId IdType="pubmed">35350632</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.D.S., et al. Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant. Children. 2022;9(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9140086</ArticleId><ArticleId IdType="pubmed">35626830</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., et al. Symptoms, complications and management of long COVID: a review. J&#xa0;R Soc Med. 2021;114(9):428&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowyer R.C.E., Huggins C., Toms R., et al. Characterising patterns of COVID-19 and long COVID symptoms: Evidence from nine UK longitudinal studies. medRxiv. 2022 2022.06.20.22275994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9860244</ArticleId><ArticleId IdType="pubmed">36680646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>